NCT00585455View on ClinicalTrials.gov

Vascular Effects of Sertraline in Heart Failure

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Heart FailureDepression
Interventions
DRUG

sertraline

open label 25-50 mg daily as tolerated

Trial Locations (1)

06510

Yale University School of Medicine, New Haven

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Yale University

OTHER